[MDGL] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
07-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -3.00%
YoY- -77.12%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 14,638 0 0 0 0 0 0 -
PBT -151,971 -85,800 -70,730 -61,651 -49,023 -19,699 -6,460 69.19%
Tax 0 3,425 780 0 -1,319 0 -1,166 -
NP -151,971 -85,800 -71,510 -61,651 -49,023 -19,699 -6,460 69.19%
Tax Rate - - - - - - - -
Total Cost 166,609 85,800 71,510 61,651 49,023 19,699 6,460 71.80%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -1,038.20 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -7.10 -4.69 -4.18 -3.72 -3.18 -1.28 -0.45 58.30%
EPS Diluted -7.10 -4.69 -4.18 -3.72 -3.18 -1.28 -0.45 58.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.